Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

Epithelial ovarian cancer

Known as: carcinoma, ovarian epithelial, Ovarian epithelial cancer, epithelial ovarian carcinoma 
A malignant neoplasm originating from the surface ovarian epithelium. It accounts for the greatest number of deaths from malignancies of the female… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2011
Review
2011
Recent morphologic, immunohistochemical, and molecular genetic studies have led to the development of a new paradigm for the… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Highly Cited
2010
Highly Cited
2010
  • R. Kurman, I. Shih
  • The American journal of surgical pathology
  • 2010
  • Corpus ID: 33753425
Ovarian cancer is the most lethal gynecologic malignancy. Efforts at early detection and new therapeutic approaches to reduce… Expand
Highly Cited
2007
Highly Cited
2007
Epithelial ovarian cancer (EOC) is the sixth most common cancer in women worldwide and, despite advances in detection and… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Highly Cited
2005
Highly Cited
2005
In a recent report, [Zhang et al. (2003) N. Engl. J. Med. 348, 203-213], the presence of CD3+ tumor-infiltrating lymphocytes… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
  • table 3
Highly Cited
2004
Highly Cited
2004
Regulatory T (Treg) cells mediate homeostatic peripheral tolerance by suppressing autoreactive T cells. Failure of host antitumor… Expand
  • figure 2
  • figure 3
  • figure 5
  • figure 6
Highly Cited
2003
Highly Cited
2003
BACKGROUND Although tumor-infiltrating T cells have been documented in ovarian carcinoma, a clear association with clinical… Expand
  • figure 1
  • figure 2
  • table 1
  • table 2
  • table 3
Highly Cited
2003
Highly Cited
2003
Germline mutations in BRCA1 and BRCA2 confer high risks of breast and ovarian cancer, but the average magnitude of these risks is… Expand
Highly Cited
1992
Highly Cited
1992
Data collected from 2,197 white ovarian cancer patients and 8,893 white controls in 12 US case-control studies conducted in the… Expand
Highly Cited
1990
Highly Cited
1990
Previous studies have suggested that overexpression of HER-2/neu oncogene occurs in 15-40% of breast cancers and that… Expand
  • figure 1
  • figure 2
  • table 2
  • table 1
  • figure 3
Highly Cited
1983
Highly Cited
1983
The murine monoclonal antibody OC 125 reacts with an antigen (CA 125) common to most nonmucinous epithelial ovarian carcinomas… Expand